Transplantation is the transfer (engraftment) of human cells, tissues, or organs from a donor to a recipient, with the aim of restoring function(s) in the body.
This report contains market size and forecasts of Transplantation Therapeutics Drugs in Global, including the following market information:
Global Transplantation Therapeutics Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Transplantation Therapeutics Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Calcineurin Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Transplantation Therapeutics Drugs include Novartis, GlaxoSmithKline, AbbVie, Pfizer, Astellas Pharma, Gilead Sciences, SBI Biotech, Sanofi and Takeda. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Transplantation Therapeutics Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Transplantation Therapeutics Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Transplantation Therapeutics Drugs Market Segment Percentages, by Type, 2021 (%)
Calcineurin Inhibitors
Anti-Proliferative Agents
Corticosteroids
Others
Global Transplantation Therapeutics Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Transplantation Therapeutics Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Transplantation Therapeutics Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Transplantation Therapeutics Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Transplantation Therapeutics Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Transplantation Therapeutics Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
GlaxoSmithKline
AbbVie
Pfizer
Astellas Pharma
Gilead Sciences
SBI Biotech
Sanofi
Takeda